Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment
Chondrosarcoma is a malignant cartilage-forming tumour of bone, of which distinct clinicopathological subtypes are known. Conventional chondrosarcoma is notorious for its locally aggressive behaviour as well as for its resistance to chemotherapy and radiotherapy; so far surgery is the only effective...
Gespeichert in:
| Veröffentlicht in: | The lancet oncology 2005-08, Vol.6 (8), p.599-607 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 607 |
|---|---|
| container_issue | 8 |
| container_start_page | 599 |
| container_title | The lancet oncology |
| container_volume | 6 |
| creator | Bovée, Judith VMG Cleton-Jansen, Anne-Marie Taminiau, Antonie HM Hogendoorn, Pancras CW |
| description | Chondrosarcoma is a malignant cartilage-forming tumour of bone, of which distinct clinicopathological subtypes are known. Conventional chondrosarcoma is notorious for its locally aggressive behaviour as well as for its resistance to chemotherapy and radiotherapy; so far surgery is the only effective therapeutic option. During the past 10 years, substantial new insights have been gained about molecular cell biology, molecular cytogenetics, and immunopathology, leading to better understanding of chondrosarcoma development at the molecular level, which will ultimately lead to better clinical understanding and possibly to the development of targeted treatment. |
| doi_str_mv | 10.1016/S1470-2045(05)70282-5 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68428953</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1470204505702825</els_id><sourcerecordid>68428953</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-b774d27844d3a680585b12e0136faa22e9463d47c0a2613259ddac59fb2a2c83</originalsourceid><addsrcrecordid>eNqFkUuLFTEQhYMozkN_ghJciC5ak3TSnV4NMsyoMODC2YfqpPreDN1Jm-SOzL839wGCG1cViq9OVc4h5A1nnzjj3eefXPasEUyqD0x97JnQolHPyHlty0ZJrZ8f3kfkjFzk_MAY7zlTL8kZ75iSqufnZLpZMG182NAVyvY3PGXqAy1bpA4fcY7rgqHQOFG7jcGlmCHZuMC-M8aAFIKjfllnb6H4GDKdYqIF0gYLOloSQtkrvCIvJpgzvj7VS3J_e3N__a25-_H1-_WXu8a2AyvN2PfSiV5L6VroNFNajVwg4203AQiBg-xaJ3vLQHS8FWpwDqwaplGAsLq9JO-PsmuKv3aYi1l8tjjPEDDusum0FHpQbQXf_QM-xF0K9TQjWPW3eiYrpI6Qrf_OCSezJr9AejKcmX0I5hCC2TtsmDKHEIyqc29P4rtxQfd36uR6Ba6OAFYrHj0mk63HYNH5hLYYF_1_VvwBWvWWwg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>201010454</pqid></control><display><type>article</type><title>Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>ProQuest Central UK/Ireland</source><creator>Bovée, Judith VMG ; Cleton-Jansen, Anne-Marie ; Taminiau, Antonie HM ; Hogendoorn, Pancras CW</creator><creatorcontrib>Bovée, Judith VMG ; Cleton-Jansen, Anne-Marie ; Taminiau, Antonie HM ; Hogendoorn, Pancras CW</creatorcontrib><description>Chondrosarcoma is a malignant cartilage-forming tumour of bone, of which distinct clinicopathological subtypes are known. Conventional chondrosarcoma is notorious for its locally aggressive behaviour as well as for its resistance to chemotherapy and radiotherapy; so far surgery is the only effective therapeutic option. During the past 10 years, substantial new insights have been gained about molecular cell biology, molecular cytogenetics, and immunopathology, leading to better understanding of chondrosarcoma development at the molecular level, which will ultimately lead to better clinical understanding and possibly to the development of targeted treatment.</description><identifier>ISSN: 1470-2045</identifier><identifier>EISSN: 1474-5488</identifier><identifier>DOI: 10.1016/S1470-2045(05)70282-5</identifier><identifier>PMID: 16054571</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Bone Neoplasms - genetics ; Bone Neoplasms - immunology ; Bone Neoplasms - physiopathology ; Bone Neoplasms - therapy ; Bones ; Cartilage ; Cartilage - growth & development ; Cell Differentiation ; Chondrosarcoma - genetics ; Chondrosarcoma - immunology ; Chondrosarcoma - physiopathology ; Chondrosarcoma - therapy ; Genes ; Humans ; Mutation ; Prognosis ; Tumors</subject><ispartof>The lancet oncology, 2005-08, Vol.6 (8), p.599-607</ispartof><rights>2005 Elsevier Ltd</rights><rights>Copyright Elsevier Limited Aug 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-b774d27844d3a680585b12e0136faa22e9463d47c0a2613259ddac59fb2a2c83</citedby><cites>FETCH-LOGICAL-c390t-b774d27844d3a680585b12e0136faa22e9463d47c0a2613259ddac59fb2a2c83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/201010454?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974,64362,64364,64366,72216</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16054571$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bovée, Judith VMG</creatorcontrib><creatorcontrib>Cleton-Jansen, Anne-Marie</creatorcontrib><creatorcontrib>Taminiau, Antonie HM</creatorcontrib><creatorcontrib>Hogendoorn, Pancras CW</creatorcontrib><title>Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment</title><title>The lancet oncology</title><addtitle>Lancet Oncol</addtitle><description>Chondrosarcoma is a malignant cartilage-forming tumour of bone, of which distinct clinicopathological subtypes are known. Conventional chondrosarcoma is notorious for its locally aggressive behaviour as well as for its resistance to chemotherapy and radiotherapy; so far surgery is the only effective therapeutic option. During the past 10 years, substantial new insights have been gained about molecular cell biology, molecular cytogenetics, and immunopathology, leading to better understanding of chondrosarcoma development at the molecular level, which will ultimately lead to better clinical understanding and possibly to the development of targeted treatment.</description><subject>Bone Neoplasms - genetics</subject><subject>Bone Neoplasms - immunology</subject><subject>Bone Neoplasms - physiopathology</subject><subject>Bone Neoplasms - therapy</subject><subject>Bones</subject><subject>Cartilage</subject><subject>Cartilage - growth & development</subject><subject>Cell Differentiation</subject><subject>Chondrosarcoma - genetics</subject><subject>Chondrosarcoma - immunology</subject><subject>Chondrosarcoma - physiopathology</subject><subject>Chondrosarcoma - therapy</subject><subject>Genes</subject><subject>Humans</subject><subject>Mutation</subject><subject>Prognosis</subject><subject>Tumors</subject><issn>1470-2045</issn><issn>1474-5488</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkUuLFTEQhYMozkN_ghJciC5ak3TSnV4NMsyoMODC2YfqpPreDN1Jm-SOzL839wGCG1cViq9OVc4h5A1nnzjj3eefXPasEUyqD0x97JnQolHPyHlty0ZJrZ8f3kfkjFzk_MAY7zlTL8kZ75iSqufnZLpZMG182NAVyvY3PGXqAy1bpA4fcY7rgqHQOFG7jcGlmCHZuMC-M8aAFIKjfllnb6H4GDKdYqIF0gYLOloSQtkrvCIvJpgzvj7VS3J_e3N__a25-_H1-_WXu8a2AyvN2PfSiV5L6VroNFNajVwg4203AQiBg-xaJ3vLQHS8FWpwDqwaplGAsLq9JO-PsmuKv3aYi1l8tjjPEDDusum0FHpQbQXf_QM-xF0K9TQjWPW3eiYrpI6Qrf_OCSezJr9AejKcmX0I5hCC2TtsmDKHEIyqc29P4rtxQfd36uR6Ba6OAFYrHj0mk63HYNH5hLYYF_1_VvwBWvWWwg</recordid><startdate>20050801</startdate><enddate>20050801</enddate><creator>Bovée, Judith VMG</creator><creator>Cleton-Jansen, Anne-Marie</creator><creator>Taminiau, Antonie HM</creator><creator>Hogendoorn, Pancras CW</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20050801</creationdate><title>Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment</title><author>Bovée, Judith VMG ; Cleton-Jansen, Anne-Marie ; Taminiau, Antonie HM ; Hogendoorn, Pancras CW</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-b774d27844d3a680585b12e0136faa22e9463d47c0a2613259ddac59fb2a2c83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Bone Neoplasms - genetics</topic><topic>Bone Neoplasms - immunology</topic><topic>Bone Neoplasms - physiopathology</topic><topic>Bone Neoplasms - therapy</topic><topic>Bones</topic><topic>Cartilage</topic><topic>Cartilage - growth & development</topic><topic>Cell Differentiation</topic><topic>Chondrosarcoma - genetics</topic><topic>Chondrosarcoma - immunology</topic><topic>Chondrosarcoma - physiopathology</topic><topic>Chondrosarcoma - therapy</topic><topic>Genes</topic><topic>Humans</topic><topic>Mutation</topic><topic>Prognosis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bovée, Judith VMG</creatorcontrib><creatorcontrib>Cleton-Jansen, Anne-Marie</creatorcontrib><creatorcontrib>Taminiau, Antonie HM</creatorcontrib><creatorcontrib>Hogendoorn, Pancras CW</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>The lancet oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bovée, Judith VMG</au><au>Cleton-Jansen, Anne-Marie</au><au>Taminiau, Antonie HM</au><au>Hogendoorn, Pancras CW</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment</atitle><jtitle>The lancet oncology</jtitle><addtitle>Lancet Oncol</addtitle><date>2005-08-01</date><risdate>2005</risdate><volume>6</volume><issue>8</issue><spage>599</spage><epage>607</epage><pages>599-607</pages><issn>1470-2045</issn><eissn>1474-5488</eissn><coden>LANCAO</coden><abstract>Chondrosarcoma is a malignant cartilage-forming tumour of bone, of which distinct clinicopathological subtypes are known. Conventional chondrosarcoma is notorious for its locally aggressive behaviour as well as for its resistance to chemotherapy and radiotherapy; so far surgery is the only effective therapeutic option. During the past 10 years, substantial new insights have been gained about molecular cell biology, molecular cytogenetics, and immunopathology, leading to better understanding of chondrosarcoma development at the molecular level, which will ultimately lead to better clinical understanding and possibly to the development of targeted treatment.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>16054571</pmid><doi>10.1016/S1470-2045(05)70282-5</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1470-2045 |
| ispartof | The lancet oncology, 2005-08, Vol.6 (8), p.599-607 |
| issn | 1470-2045 1474-5488 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68428953 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present); ProQuest Central UK/Ireland |
| subjects | Bone Neoplasms - genetics Bone Neoplasms - immunology Bone Neoplasms - physiopathology Bone Neoplasms - therapy Bones Cartilage Cartilage - growth & development Cell Differentiation Chondrosarcoma - genetics Chondrosarcoma - immunology Chondrosarcoma - physiopathology Chondrosarcoma - therapy Genes Humans Mutation Prognosis Tumors |
| title | Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T16%3A41%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Emerging%20pathways%20in%20the%20development%20of%20chondrosarcoma%20of%20bone%20and%20implications%20for%20targeted%20treatment&rft.jtitle=The%20lancet%20oncology&rft.au=Bov%C3%A9e,%20Judith%20VMG&rft.date=2005-08-01&rft.volume=6&rft.issue=8&rft.spage=599&rft.epage=607&rft.pages=599-607&rft.issn=1470-2045&rft.eissn=1474-5488&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1470-2045(05)70282-5&rft_dat=%3Cproquest_cross%3E68428953%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=201010454&rft_id=info:pmid/16054571&rft_els_id=S1470204505702825&rfr_iscdi=true |